Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter S Loewen
Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke Be Extended to 4.5 Hours?
Canadian Journal of Hospital Pharmacy
Pharmacology
Pharmacy
Related publications
Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
Case Reports in Critical Care
Simultaneous Treatment With Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?
Neurology International
Neurology
Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke
The Egyptian Journal of Hospital Medicine
Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke
Expert Opinion on Drug Delivery
Pharmaceutical Science
Genome Response to Tissue Plasminogen Activator in Experimental Ischemic Stroke
BMC Genomics
Biotechnology
Genetics
Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (R-Tpa) in Acute Ischemic Stroke
Jentashapir Journal of Health Research